InvestorsHub Logo
Followers 86
Posts 4531
Boards Moderated 0
Alias Born 09/25/2010

Re: John_Langston post# 128577

Sunday, 09/28/2014 12:41:40 AM

Sunday, September 28, 2014 12:41:40 AM

Post# of 404757
Potentially, but I would hope not after the debacle that was Targiniq and the FDA's stated priority for abuse deterrent opioids..... but one never knows with the FDA, hence my point.

ps: probuphine is going to be resubmitted in 2015 after conclusion of another Phase 3 trial currently enrolling and the odds of approval look substantially better on the next submission imo.

Life is what you make it...Buy intelligently ..
..sell reluctantly...


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News